MedLumics welcomes Rich Ferrari to its Board as Chairman along with closing €18m financing round led by Asabys Partners joined by Kurma Partners

– SPAIN, Madrid –  MedLumics, a privately held medical device company developing AblaView, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation, today announced that it has closed an upsized €18 million financing round led by Asabys Partners and joined by Kurma Partners along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II.…

Synendos Therapeutics adds Dr Peter Neubeck, Dr Søren Lemonius and Dr Bettina Ernst to Board along with raising CHF20m Series A financing co-led by Kurma Partners and Sunstone Life Science Ventures

– SWITZERLAND, Basel –  Synendos Therapeutics, a biopharmaceutical company developing a new class of small molecules aimed at restoring the natural functioning of the endocannabinoid system in the brain with the potential for treating a wide range of Central Nervous System (CNS) disorders, today announced the company has raised CHF 20 million in a Series A financing co-led by Kurma Partners and Sunstone Life Science Ventures and participation from BERNINA BioInvest, Schroder Adveq, High-Tech Gründerfonds, Lichtsteiner Foundation, Essential Investments, Zürcher Kantonalbank and private investors.…

Vico Therapeutics strengthens its Board along with raising $31m Series A financing co-led by Life Science Partners and Kurma Partners

– NETHERLANDS, Leiden – Vico Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, today announced that it has raised $31 million (€27 million) in a Series A financing round led by Life Science Partners, co-led by Kurma Partners, and supported by Pontifax, Droia Genetic Disease, Polaris Partners and Pureos Bioventures and Idinvest Partners.…